Juvenile Rheumatoid Arthritis

A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA

NCT01709760 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)

NCT03265132 ·Status: TERMINATED ·Phase: PHASE3

Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

NCT03932344 ·Status: COMPLETED

Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

NCT00078806 ·Status: TERMINATED ·Phase: PHASE3

Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis

NCT00443430 ·Status: COMPLETED ·Phase: PHASE4

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

NCT01787149 ·Status: UNKNOWN ·Phase: PHASE3

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

NCT00962741 ·Status: COMPLETED ·Phase: PHASE3

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

NCT00522184 ·Status: COMPLETED ·Phase: PHASE3

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)

NCT00886769 ·Status: TERMINATED ·Phase: PHASE3

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

NCT00244556 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis

NCT00888745 ·Status: COMPLETED ·Phase: PHASE1

Enbrel Liquid Immunogenicity Protocol

NCT00249041 ·Status: COMPLETED ·Phase: PHASE3

Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease

NCT01566201 ·Status: COMPLETED ·Phase: NA

Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis

NCT00213538 ·Status: COMPLETED

Study Evaluating the Efficacy and Safety of Etanercept

NCT00546533 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study

NCT01033656 ·Status: COMPLETED ·Phase: PHASE2

Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)

NCT00117091 ·Status: COMPLETED ·Phase: PHASE3

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

NCT00110903 ·Status: COMPLETED ·Phase: PHASE3

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

NCT01783015 ·Status: TERMINATED ·Phase: PHASE4

Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis

NCT03410056 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

NCT02373813 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis

NCT00505089 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study Evaluating Enbrel in Patients With Rheumatoid Arthritis

NCT00245934 ·Status: COMPLETED

Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)

NCT00099554 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone

NCT00579644 ·Status: COMPLETED ·Phase: PHASE3